Option chain shows key data for Kayne Anderson BDC's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Kayne Anderson BDC.

Kayne Anderson BDC (NYSE:KBDC) Stock, Option Chain

Kayne Anderson BDC

Kayne Anderson BDC Inc is a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.

Wall Street ai5

Long Ideas

News

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

CULP

KBDC

SIGI

Insiders Buying Selective Insurance And 2 Other Stocks

Kayne Anderson BDC Inc

KINGBOARD CHEML HLDGS ORD by Kingboard Holdings Ltd.

Kingboard Holdings Ltd

KINGBOARD HLDGS UNS/ADR by Kingboard Holdings Ltd.

WIIM

ARDT

Ardent Health Partners shares are trading higher after the company reported better-than-expected Q4 financial results.

Cantor Fitzgerald analyst Ross Osborn reiterates MiMedx Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>) with a Overweight and maintains $13 price target.

Price Target

Reiteration

Analyst Ratings

MDXG

Cantor Fitzgerald Reiterates Overweight on MiMedx Group, Maintains $13 Price Target

HubSpot's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) short percent of float has fallen 17.54% since its last report. The company recently reported that it has 709 thousand shares sold short, which is 1.41% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.22 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>HubSpot Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740673840_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for HubSpot has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing HubSpot's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, HubSpot's peer group average for short interest as a percentage of float is 3.05%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

HUBS

Peering Into HubSpot's Recent Short Interest

British American Tobacco's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) short percent of float has risen 22.86% since its last report. The company recently reported that it has 7.19 million shares sold short, which is 0.43% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.24 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>British American Tobacco Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740673835_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for British American Tobacco has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing British American Tobacco's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, British American Tobacco's peer group average for short interest as a percentage of float is 2.69%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on British American Tobacco?

Walgreens Boots Alliance's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NYSE">WBA</a>) short percent of float has risen 5.57% since its last report. The company recently reported that it has 67.05 million shares sold short, which is 9.29% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.84 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Walgreens Boots Alliance Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740673829_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Walgreens Boots Alliance has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Walgreens Boots Alliance's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Walgreens Boots Alliance's peer group average for short interest as a percentage of float is 1.56%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Walgreens Boots Alliance's Recent Short Interest

Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) has outperformed the market over the past 15 years by 10.91% on an annualized basis producing an average annual return of 22.54%. Currently, Take-Two Interactive has a market capitalization of $36.81 billion. 
Buying $100 In TTWO: If an investor had bought $100 of TTWO stock 15 years ago, it would be worth $2,102.99 today based on a price of $209.58 for TTWO at the time of writing.
<h3>Take-Two Interactive's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740673810_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TTWO

Here's How Much You Would Have Made Owning Take-Two Interactive Stock In The Last 15 Years

Melco Resorts &amp; Entertainment Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLCO#NASDAQ">MLCO</a>) shares are <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g44004189/melco-announces-unaudited-fourth-quarter-2024-earnings" rel="noreferrer noopener">trading higher on Thursday.</a>
The company reported fourth-quarter adjusted loss per ADS of $0.005, compared with the analyst consensus estimate of $0.08 earnings. Quarterly sales of $1.19 billion (up 9% year over year) outpaced the analyst consensus of $1.17 billion.
The increase in total operating revenues was primarily attributable to the improved performance in all gaming segments and non-gaming operations.
Operating income for the fourth quarter was $97.0 million, compared with an operating loss of $94.4 million in the year-ago period.
Melco generated Adjusted Property EBITDA&nbsp;of $295.4 million, lower than $303.4 million in the year-ago period.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/econ-s/25/02/44007082/q4-gdp-holds-at-2-3-after-minor-revision-in-second-estimate" rel="noreferrer noopener">Q4 GDP Holds At 2.3% After Minor Revision In Second Estimate</a>
&#8220;We are committed to continuing to deliver on our strategic objectives and expect to continue to unveil new and exciting projects to support the ongoing growth in Macau,&#8221; Lawrence Ho, Chairman and Chief Executive Officer, commented.
&#8220;And last, but not least, the development of the casino at City of Dreams Sri Lanka is progressing well and we expect to commence casino operations in the third quarter of 2025,&#8221; Ho added.
Total cash and bank balances, as of December 31, aggregated to $1.27 billion, including $125.9 million of restricted cash.
Long-term prepayments (deposits and other assets) expanded to $131.85 million from $100.320 million in the year-ago period.
Melco Resorts also announced that it is evaluating potential strategic alternatives in relation to City of Dreams Manila.
Price Action: MLCO shares are trading higher by 1.83% at $5.835 at the time of publication.
Read Next:<a target="_blank" href="https://www.benzinga.com/government/regulations/25/02/43903335/financial-crime-weekly-1-4-billion-ethereum-stolen-in-largest-crypto-hack-ever-sec-creates-cyber-and-emerging-technologies-unit" rel="noreferrer noopener">&nbsp;</a>
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43949800/tesla-competes-against-chinese-rivals-with-one-hand-tied-behind-its-back-analyst" target="_blank" rel="noreferrer noopener">Tesla Competes Against Chinese Rivals ‘With One Hand Tied Behind Its Back': Analyst</a></li>
</ul>
Image via Shutterstock.

Earnings

Equities

Guidance

Movers

General

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

Melco Resorts Q4 Revenues Rise Amid Improved Performance In All Gaming Segments: Details

APA Says In November, It Added A Rig In Egypt To Initiate A Gas-focused Drilling Program; Expects Year Over Year, Gas Production To Increase For The First Time In Over A Decade From The Program; Says It Reduced Its Corporate Officer Count By Over One-Third As A Part Of Cost Cutting Plan Announced In January

Keybanc analyst John Vinh maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Overweight and raises the price target from $210 to $220.

SNOW

Keybanc Maintains Overweight on Snowflake, Raises Price Target to $220

Petrobras CEO Says Buzios Field Expected To Produce 2M Barrels/day By 2030 With New FPSOS Coming Online; Petrobras' CapEx In Q1 Of 2025 Will Not Be At The Level Of Q4 Of 2024; Says Petrobras Understands Investors' Frustration With Dividends, But Chose To Push Forward Investments To 2024

Susquehanna analyst Shyam Patil maintains Magnite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNI#NASDAQ">MGNI</a>) with a Positive and raises the price target from $16 to $22.

MGNI

Susquehanna Maintains Positive on Magnite, Raises Price Target to $22

J M Smucker Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJM#NYSE">SJM</a>) reported <a href="https://www.benzinga.com/pressreleases/25/02/n44002388/the-j-m-smucker-co-announces-fiscal-2025-third-quarter-results">third-quarter FY25 sales decline</a> of 2% year-on-year to $2.19 billion, missing the analyst consensus estimate of $2.22 billion.
Gross profit for the quarter increased 7% to $878.1 million and the gross margin expanded 330 basis points to 40.2%.
The company reported an operating loss of $594 million compared to an operating income of $297.4 million.
Adjusted EPS of $2.61 <a href="https://www.benzinga.com/earnings">beat the analyst consensus</a> estimate of $2.37. Operating cash flow totaled&nbsp;$239.4 million with a free cash flow was&nbsp;$151.3 million.
Also Read: <a href="https://www.benzinga.com/news/25/02/43980853/why-is-mullen-automotive-stock-skyrocketing-today">Mullen EVs Receives Approval For Government And Educational Purchases</a>
The company held $47.2 million in cash and equivalents as of January 31, 2025.
&#8220;Net sales for the quarter would have been above our expectations, however, we experienced certain supply chain disruptions that negatively impacted results. Disciplined cost management and execution enabled us to deliver adjusted earnings per share that exceeded our expectations,&#8221; said Chair of the Board, President, and CEO Mark Smucker.
Outlook: J M Smucker lowered the FY25 sales growth outlook from 7.50% &#8211; 8.50% to 7.25%.
However, the company raised the FY25 adjusted EPS guidance from $9.70 &#8211; $10.10 to $9.85 &#8211; $10.15.
Capital expenditure for the year is expected to be $400 million &#8211; $450 million.
Price Action: SJM shares are trading higher by 0.59% at $109.81 at last check Thursday.
Read Next: <a href="https://www.benzinga.com/news/earnings/25/02/43973849/budweiser-parent-anheuser-busch-says-beer-is-a-passion-point-for-consumers-on-strong-q4-performance">Budweiser Parent Anheuser-Busch Says &#8216;Beer Is A Passion Point For Consumers&#8217; On Strong Q4 Performance</a>
Image via Shutterstock

J M Smucker's Q3: Sales Decline, Operating Loss And More

Susquehanna analyst Christopher Stathoulopoulos maintains AerCap Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AER#NYSE">AER</a>) with a Positive and raises the price target from $108 to $120.

Susquehanna Maintains Positive on AerCap Holdings, Raises Price Target to $120

Keybanc analyst Jackson Ader maintains Dycom Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DY#NYSE">DY</a>) with a Overweight and lowers the price target from $229 to $201.

Keybanc Maintains Overweight on Dycom Industries, Lowers Price Target to $201

Dell Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) will be reporting its fourth-quarter earnings on Thursday. Wall Street expects $2.53 in EPS and $24.56 billion in revenues as the company reports<a href="https://www.benzinga.com/calendars/earnings?tickers=DELL" target="_blank" rel="noreferrer noopener"> after market hours</a>.
The stock is up 26.31% over the past year, down 0.76% year-to-date.
Let&#8217;s look at what the charts indicate for Dell stock and how the stock currently maps against Wall Street estimates.
Read Also: <a href="https://www.benzinga.com/25/02/43908370/amd-reshapes-strategy-plans-4-billion-data-center-asset-sale-while-doubling-down-on-gpus">AMD Reshapes Strategy, Plans $4 Billion Data Center Asset Sale While Doubling Down on GPUs</a>
<h2 class="wp-block-heading">Dell Stock Strongly Bullish Ahead Of Q4 Earnings</h2>
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022725&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="629" height="490" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/27104622/Screenshot-2025-02-27-at-9.16.04-PM.png" alt="" class="wp-image-801874" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/27104622/Screenshot-2025-02-27-at-9.16.04-PM.png 629w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/27104622/Screenshot-2025-02-27-at-9.16.04-PM-300x234.png 300w" sizes="(max-width: 629px) 100vw, 629px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022725&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
Dell stock is exhibiting a strongly bullish trend. Its share price is trading above its five-day, 20-day and 50-day exponential moving averages. This suggests sustained buying pressure, reinforcing the stock's positive momentum.
The Moving Average Convergence Divergence (MACD) indicator at 0.94 further supports the bullish outlook, signaling potential upward movement. Additionally, the 20-day and 50-day simple moving averages (SMA) at $111.04 and $112.98, respectively, are either below or right next to the stock, indicating continued strength in the short- to mid-term.
However, there are some mixed signals. The eight-day SMA at $116.52 creates a bearish signal, suggesting some near-term resistance. The 200-day SMA at $122.99, well above the current price, indicates a longer-term downtrend. This could act as a hurdle for sustained gains.
With a Relative Strength Index (RSI) of 49.90, DELL stock is in neutral territory, suggesting the stock is neither overbought nor oversold. Investors should watch for a break above the 200-day SMA for confirmation of a sustained bullish trend, while any dips toward the 50-day SMA could present buying opportunities.
<h2 class="wp-block-heading">Dell Analysts See 24% Upside</h2>
Ratings &amp; Consensus Estimates:<a href="https://www.benzinga.com/quote/DELL/analyst-ratings" target="_blank" rel="noreferrer noopener"> The consensus analyst rating</a> on Dell stock stands at a Buy currently with a price target of $134.05. The latest analyst ratings from Citigroup, BofA Securities and Morgan Stanley imply a 23.89% upside for Dell stock, with an average price target of $141.
DELL Price Action: Dell stock was trading at $112.85 at the time of publication.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/44005208/nvidia-ai-juggernaut-rolls-on-but-can-arista-cisco-keep-up">Nvidia Dominance Continues As AI Demand Grows: Can Arista, Cisco Keep Up?</a></li>
</ul>
Image: Shutterstock

Technicals

Previews

Tech

DELL

Dell Stock Chart Looks Bullish, But Can Q4 Earnings Power It Past Resistance?

On Thursday,&nbsp;Novavax Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) reported fourth-quarter 2024 sales of $88.31 million, compared to&nbsp;$291 million&nbsp;a year, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $84.35 million</a>. The decrease was due to lower product sales under APA agreements.
The COVID-19 vaccine maker reported an earning loss of 51 cents per share, down from $1.44 a year ago, in line <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n44004179/novavax-reports-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights" rel="noreferrer noopener">with the Wall Street Estimate</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42323263/wegovy-maker-novo-nordisk-to-buy-novavaxs-czech-republic-manufacturing-facility-for-200-million" rel="noreferrer noopener">Wegovy Maker Novo Nordisk To Buy Novavax&#8217;s Czech Republic Manufacturing Facility For $200 Million</a>
&#8220;In 2024, we unveiled our new corporate growth strategy, shifting our focus from commercializing our COVID-19 vaccine to maximizing the value of our cutting-edge technology platform through pipeline expansion and partnerships for our development-stage vaccine candidates and our Matrix-M adjuvant,&#8221; said&nbsp;John C. Jacobs, President and Chief Executive Officer, Novavax. &#8220;As we look to 2025 and beyond, we believe we are well positioned to potentially create significant value for all stakeholders.&#8221;
Nuvaxovid sales reached $49.8 million, down from $251.5 million a year ago. The company ended 2024 with over&nbsp;$1 billion&nbsp;in cash and accounts receivables.
Novavax has transitioned the lead commercial responsibility of Nuvaxovid to Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) for select markets beginning with the 2025-<a target="_blank" href="https://www.benzinga.com/general/biotech/24/05/38758287/some-breather-for-novavaxs-covid-19-vaccine-inks-multibillion-dollar-deal-with-sanofi-and-erases-" rel="noreferrer noopener">2026 vaccination season</a>.
Since Novavax is reliant on Sanofi&#8217;s sales forecasts for certain revenue components, these will not be included in the 2025 Revenue Framework at this time.
Novavax expects to achieve adjusted licensing, royalties, and other revenue of between&nbsp;$300 million&nbsp;and $350 million in 2025. Novavax is eligible to receive royalties in the high teens to low twenties percent on Sanofi sales.
<h2 class="wp-block-heading">Novavax Stock Prediction For 2025</h2>
Equity research can be a valuable source of information for learning about a company's fundamentals. Analysts create financial models based on the fundamentals and expected future earnings of a company to arrive at a price target and recommendation for the stock.
Shares of Novavax have an average 1-year price target of $19.0, representing an expected upside of 141.41%.
Because of differences in assumptions, analysts can arrive at very different price targets and recommendations. No analysts have bearish recommendations on Novavax, while 1 analysts have bullish ratings. The street high price target from HC Wainwright &amp; Co. is $19.0, while the street low from HC Wainwright &amp; Co. is $19.0.
Price Action: NVAX stock is up 10.4% at $8.08 at the last check Thursday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/44010386/why-is-ad-giant-wpp-stock-falling-today" target="_blank" rel="noreferrer noopener">Why Is Ad Giant WPP Stock Falling Today?</a></li>
</ul>

Biotech

Health Care

NVAX

Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value

Oddity Tech shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY25 EPS guidance above estimates.

KNTK

Kinetik Holdings shares are trading lower after the company reported worse-than-expected Q4 financial results.

Keybanc analyst John Vinh maintains C3.ai (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) with a Underweight and lowers the price target from $29 to $21.

Comments

Kayne Anderson BDC

Kayne Anderson BDC (KBDC) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga